What are the consensus estimates for VIRPAX PHARMACEUTICALS INC (VRPX) next earnings?
The consensus EPS estimate for the next earnings of VIRPAX PHARMACEUTICALS INC (VRPX) is -5.35 USD and the consensus revenue estimate is 0 USD.
VIRPAX PHARMACEUTICALS INC (VRPX) Forecast, Price Target & Analyst Ratings
NASDAQ:VRPX • US9282512063
Current stock price
0.6695 USD
-0.55 (-45.12%)
At close:
0.4498 USD
-0.22 (-32.82%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIRPAX PHARMACEUTICALS INC (VRPX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q1 / 2025
- EPS Estimate
- -$5.36
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.67 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
VRPX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about VRPX.
In the previous month the buy percentage consensus was at a similar level.
VRPX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-10-09 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-07-19 | Maxim Group | Upgrade | Hold -> Buy |
| 2024-05-22 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-06-09 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q1 / 2025
- EPS Estimate
- -$5.36
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- N/A
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-2,400.00%
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 46.30% | N/A 34.85% | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.626M | -3.182M -21.17% | -4.196M -31.86% | -12.026M -186.61% | -21.845M -81.66% | -15.69M 28.18% | -12.08M 23.01% | N/A 24.07% | N/A -9.81% | N/A -10.53% | N/A 505.90% | N/A 83.41% | N/A 50.78% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A -12,821.35% | N/A 64.13% | N/A 81.21% | N/A 19.35% | N/A -6.00% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 25 | Q2 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -5.36 | -4.59 -162.29% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.472M 25.13% | -2.349M 32.08% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
22.53%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A